Latest news
OliX Hires RNAi Expert Min Ji-young as EVP to Boost Licensing - Seoul Economic DailySeoul Economic Daily · Mon, 10 Aug 2026 05:44:21 GMTOliX taps GSK veteran Min Ji-young to drive global RNAi development - CHOSUNBIZ - ChosunbizChosunbiz · Mon, 10 Aug 2026 04:28:00 GMTWVE: Strong clinical progress in RNAi/editing pipeline, robust cash runway, and key trials advancing - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMTRenaissance BioScience Receives Genome BC Funding to Extend RNAi Biopesticide Platform to Target Soil-Dwelling Crop Pests - AgriBusiness GlobalAgriBusiness Global · Wed, 29 Jul 2026 14:20:35 GMTThe Evolution and History of RNA Interference Therapeutics - the-scientist.comthe-scientist.com · Wed, 29 Jul 2026 07:16:15 GMTAlnylam (ALNY) Is Up 6.3% After Showcasing New Alzheimer’s RNAi Data And $1B-Plus Quarterly Revenue - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT